INOMAX Side Effects

6968181-3 | Oxygen Saturation Decreased
on Aug 18, 2010 Male patient from UNITED STATES , 38 years of age, was diagnosed with oxygen saturation decreased and was treated with Inomax (View Usage). Patient experienced the following unwanted or unexpected effects: oxygen saturation decreased. Inomax dosage: 80 Ppm;cont;inh.

6882372-1 | Device Leakage, Oxygen Saturation Decreased
Patient was taking Inomax (View Usage). Patient had the following side effects: device leakage, oxygen saturation decreased on Jul 12, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 1.52 lb, was diagnosed with bronchopulmonary dysplasia, neonatal respiratory distress syndrome and. Inomax dosage: 20 Ppm;cont;inh.

6836719-2 | Cardiac Failure, Device Malfunction, No Therapeutic Response, Unevaluable Event
Adverse event was reported on Jun 23, 2010 by a Female patient taking Inomax (View Usage) (Dosage: 40 Ppm; Cont Inh; 55 Ppm; Cont; Inh,) was diagnosed with pulmonary arterial pressure, pulmonary arterial pressure increased and. Location: UNITED STATES , 27 years of age, After Inomax was administered, patient had the following side effects: cardiac failure, device malfunction, no therapeutic response, unevaluable event. During the same period patient was treated with INCOVENT (DELIVERY SYSTEM) (View Incovent (delivery System) Review and Incovent (delivery System) Label ).

6696161-4 | Dilatation Atrial, Pulmonary Artery Dilatation, Pulmonary Embolism, Pulmonary Hypertension, Right Ventricular Dysfunction, Right Ventricular Hypertrophy, Tricuspid Valve Incompetence
on Apr 06, 2010 Female patient from UNITED KINGDOM , 16 years of age, weighting 110.2 lb, was diagnosed with mean arterial pressure decreased, pulmonary hypertension (What is pulmonary hypertension?) and was treated with Inomax (View Usage). Patient experienced the following unwanted or unexpected effects: dilatation atrial, pulmonary artery dilatation, pulmonary embolism (What is pulmonary embolism?), pulmonary hypertension (What is pulmonary hypertension?), right ventricular dysfunction, right ventricular hypertrophy, tricuspid valve incompetence. Inomax dosage: 19 Ppm;inh. Patient was hospitalized.


6686723-2 |
on Mar 30, 2010 Male patient from UNITED STATES , 18 years of age, was diagnosed with pulmonary haemorrhage and was treated with Inomax (View Usage). . Inomax dosage: 80 Ppm;cont;inh.

6666417-X | Cardio-respiratory Arrest, Device Malfunction, Hypotension, Medical Device Complication, Oxygen Saturation Decreased
Patient was taking Inomax (View Usage). After Inomax was administered, patient had the following side effects: cardio-respiratory arrest, device malfunction, hypotension, medical device complication, oxygen saturation decreased on Mar 22, 2010 from UNITED STATES Additional patient health information: Male patient , 79 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Inomax dosage: 80 Ppm; Cont; Inh.

6657836-6 | Blood Pressure Decreased, Cardiac Arrest, Device Malfunction, Heart Rate Decreased, Ventricular Fibrillation
Adverse event was reported on Mar 17, 2010 by a Male patient taking Inomax (View Usage) (Dosage: 20 Ppm;cont;inh, 40ppm; Cont; Inh) was diagnosed with h1n1 influenza, pulmonary hypertension (What is pulmonary hypertension?) and. Location: UNITED STATES , 20 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, cardiac arrest (What is cardiac arrest?), device malfunction, heart rate decreased, ventricular fibrillation.

6414617-6 | Device Failure, Oxygen Saturation Decreased
on Oct 05, 2009 Male patient from UNITED STATES , child 6 years of age, weighting 59.30 lb, was diagnosed with acute respiratory distress syndrome and was treated with Inomax (View Usage). Patient had the following side effects: device failure, oxygen saturation decreased. Inomax dosage: 40 Ppm;cont. During the same period patient was treated with INOVENT (DELIVERY SYSTEM) (View Inovent (delivery System) Review and Inovent (delivery System) Label ).

6331919-2 | Thrombocytopenia
on Aug 11, 2009 Male patient from UNITED STATES , weighting 7.85 lb, was diagnosed with pulmonary arterial pressure increased and was treated with Inomax (View Usage). After Inomax was administered, patient had the following side effects: thrombocytopenia. Inomax dosage: 20 Ppm; Cont; Inh, 15 Ppm; Cont; Inh, 10 Ppm; Cont; Inh, 1 Ppm; Cont; Inh.

6260770-7 | Device Failure, Device Malfunction, Oxygen Saturation Decreased
Patient was taking Inomax (View Usage). Patient experienced the following unwanted or unexpected effects: device failure, device malfunction, oxygen saturation decreased on Jun 25, 2009 from UNITED STATES Additional patient health information: Female patient , child 3 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Inomax dosage: 20 Ppm; Cont; Inh.

6255637-4 | Cardiac Arrest, Pulmonary Embolism
Adverse event was reported on Jun 19, 2009 by a Male patient taking Inomax (View Usage) (Dosage: 80 Ppm; Cont; Inh) was diagnosed with acute respiratory distress syndrome, oxygen saturation abnormal and. Location: UNITED STATES , 30 years of age, weighting 196.0 lb, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), pulmonary embolism (What is pulmonary embolism?).

6250097-1 | Cardiac Arrest
on Jun 10, 2009 Female patient from UNITED STATES , 37 years of age, was diagnosed with vascular test and was treated with Inomax (View Usage). After Inomax was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?). Inomax dosage: 10 Ppm;cont;inh ; 20 Ppm;cont;inh ; 40 Ppm;cont;inh ; 80 Ppm;cont;inh.

5902602-X | Aspiration, Device Failure, Heart Rate Decreased, Hepatic Congestion, Hepatic Fibrosis, Procedural Complication, Pulmonary Embolism, Pulmonary Haemorrhage, Right Ventricular Failure
on Sep 19, 2008 Female patient from UNITED STATES , 38 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Inomax (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration, device failure, heart rate decreased, hepatic congestion, hepatic fibrosis, procedural complication, pulmonary embolism (What is pulmonary embolism?), pulmonary haemorrhage, right ventricular failure. Inomax dosage: 20 Ppm;cont;inh.

5899378-1 | Cardio-respiratory Arrest, Device Malfunction, Oxygen Saturation Decreased
Patient was taking Inomax (View Usage). Patient had the following side effects: cardio-respiratory arrest, device malfunction, oxygen saturation decreased on Sep 08, 2008 from UNITED STATES Additional patient health information: Male patient , 56 years of age, weighting 227.1 lb, was diagnosed with acute respiratory distress syndrome, hypoxia, lung injury and. Inomax dosage: 40 Ppm; Cont; Inh.

5887259-9 | Cardio-respiratory Arrest, Device Failure, Pulmonary Embolism
Adverse event was reported on Aug 29, 2008 by a Female patient taking Inomax (View Usage) (Dosage: 20 Ppm;cont;inh) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 38 years of age, After Inomax was administered, patient had the following side effects: cardio-respiratory arrest, device failure, pulmonary embolism (What is pulmonary embolism?).

5877492-4 | Hypotension, Pulmonary Oedema, Vomiting
on Aug 28, 2008 Female patient from UNITED STATES , 70 years of age, weighting 140.2 lb, was diagnosed with myocardial infarction and was treated with Inomax (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, pulmonary oedema, vomiting. Inomax dosage: 80 Ppm;cont;inh. During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), REOPRO (View Reopro Review and Reopro Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ), PIPERACILLIN (View Piperacillin Review and Piperacillin Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.

5804009-2 | Atrial Fibrillation, Blood Pressure Decreased, Device Failure, Oxygen Saturation Decreased
on Jun 23, 2008 Female patient from UNITED STATES , 57 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Inomax (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), blood pressure decreased, device failure, oxygen saturation decreased. Inomax dosage: 20 Ppm; Cont; Inh; 10 Ppm; Cont; Inh; 7 Ppm; Cont; Inh.

5788197-2 | Blood Pressure Decreased, Device Failure
Patient was taking Inomax (View Usage). After Inomax was administered, patient had the following side effects: blood pressure decreased, device failure on Jun 09, 2008 from UNITED STATES Additional patient health information: Female patient , 57 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Inomax dosage: 20 Ppm; Cont; Inh, 10 Ppm; Cont;. During the same period patient was treated with INOMAX DF (DELIVERY SYSTEM) (View Inomax Df (delivery System) Review and Inomax Df (delivery System) Label ).

5767019-X | Blood Pressure Decreased, Device Failure
Adverse event was reported on May 23, 2008 by a Female patient taking Inomax (View Usage) (Dosage: Cont; Inh) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: UNITED STATES , 57 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, device failure.

5732595-X | Coagulopathy, Haematoma, Haemodialysis, Hepatic Failure, Multi-organ Failure, Post Procedural Complication, Pulmonary Artery Dilatation, Renal Failure
on Apr 29, 2008 Female patient from UNITED STATES , 63 years of age, weighting 121.5 lb, was diagnosed with ventricular assist device insertion and was treated with Inomax (View Usage). Patient had the following side effects: coagulopathy, haematoma, haemodialysis, hepatic failure, multi-organ failure, post procedural complication, pulmonary artery dilatation, renal failure. Inomax dosage: 20 Ppm;cont;inh. During the same period patient was treated with AMIODARONE (View Amiodarone Review and Amiodarone Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), SODIUM NITROPRUSSIDE (View Sodium Nitroprusside Review and Sodium Nitroprusside Label ), PROPOFOL (View Propofol Review and Propofol Label ), INSULIN (View Insulin Review and Insulin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MILRINONE LACTATE (View Milrinone Lactate Review and Milrinone Lactate Label ).

5706537-7 | Acute Chest Syndrome
on Apr 02, 2008 Male patient from UNITED STATES , 13 years of age, weighting 84.44 lb, was diagnosed with sickle cell anaemia and was treated with Inomax (View Usage). After Inomax was administered, patient had the following side effects: acute chest syndrome. Inomax dosage: 80 Ppm; Cont; Inh, 40 Ppm; Cont; Inh, 6 Ml; Cont; Inh. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ), HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ), COLACE (View Colace Review and Colace Label ), ATARAX (View Atarax Review and Atarax Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

5699290-7 | Anaemia, Haemolytic Transfusion Reaction, Joint Effusion, Pain, Pneumonia, Pyrexia, Sickle Cell Anaemia With Crisis, Thrombocythaemia
Patient was taking Inomax (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, haemolytic transfusion reaction, joint effusion, pain (What is pain?), pneumonia (What is pneumonia?), pyrexia, sickle cell anaemia with crisis, thrombocythaemia on Mar 25, 2008 from UNITED STATES Additional patient health information: Female patient , 31 years of age, weighting 121.0 lb, was diagnosed with sickle cell anaemia with crisis and. Inomax dosage: 80 Ppm; Cont; Inh. Patient was hospitalized.

5637763-3 | Medical Device Complication, Oxygen Saturation Decreased, Underdose
Adverse event was reported on Feb 04, 2008 by a Female patient taking Inomax (View Usage) (Dosage: 60 Ppm; Cont) . Location: UNITED STATES , 45 years of age, weighting 229.0 lb, Patient had the following side effects: medical device complication, oxygen saturation decreased, underdose.

5630365-4 | Hypotension, Pulmonary Oedema, Vomiting
on Jan 28, 2008 Female patient from UNITED STATES , 70 years of age, weighting 140.2 lb, was diagnosed with myocardial infarction and was treated with Inomax (View Usage). After Inomax was administered, patient had the following side effects: hypotension, pulmonary oedema, vomiting. Inomax dosage: 80 Ppm;cont;inh. During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), REOPRO (View Reopro Review and Reopro Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ), PIPERACILLIN (View Piperacillin Review and Piperacillin Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.

5628918-2 | Cardio-respiratory Arrest, Device Failure
on Feb 01, 2008 Female patient from UNITED STATES , 54 years of age, weighting 159.4 lb, was diagnosed with hypoxia and was treated with Inomax (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, device failure. Inomax dosage: 20 Ppm; Cont; Inh.

5623987-8 | Bradycardia Neonatal, Cardio-respiratory Arrest, Hypotonia Neonatal, Medical Device Complication, Oxygen Saturation Decreased
Patient was taking Inomax (View Usage). Patient had the following side effects: bradycardia neonatal, cardio-respiratory arrest, hypotonia neonatal, medical device complication, oxygen saturation decreased on Feb 11, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 7.94 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Inomax dosage: 20 Ppm;cont;inh.

5623983-0 | Cardio-respiratory Arrest, Device Failure, Oxygen Saturation Decreased, Pulmonary Arterial Wedge Pressure Decreased
Adverse event was reported on Feb 08, 2008 by a Female patient taking Inomax (View Usage) (Dosage: 20 Ppm;cont;inh) was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Location: UNITED STATES , 28 years of age, weighting 124.0 lb, After Inomax was administered, patient had the following side effects: cardio-respiratory arrest, device failure, oxygen saturation decreased, pulmonary arterial wedge pressure decreased. During the same period patient was treated with RENACIDIN (View Renacidin Review and Renacidin Label ), EPOPROSTENOL SODIUM (View Epoprostenol Sodium Review and Epoprostenol Sodium Label ).

5622585-X | Device Malfunction, Oxygen Saturation Decreased
on Feb 08, 2008 Male patient from UNITED STATES , 51 years of age, weighting 388.0 lb, was diagnosed with vasodilation procedure and was treated with Inomax (View Usage). Patient experienced the following unwanted or unexpected effects: device malfunction, oxygen saturation decreased. Inomax dosage: 1 Ppm;cont;inh.

5592625-5 | Cardio-respiratory Arrest, Device Failure, Pulmonary Arterial Pressure Increased
on Jan 04, 2008 Female patient from UNITED STATES , 28 years of age, weighting 124.0 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Inomax (View Usage). Patient had the following side effects: cardio-respiratory arrest, device failure, pulmonary arterial pressure increased. Inomax dosage: 20 Ppm;cont;inh. During the same period patient was treated with RENACIDIN (View Renacidin Review and Renacidin Label ), EPOPROSTENOL SODIUM (View Epoprostenol Sodium Review and Epoprostenol Sodium Label ).

5590370-3 | Bradycardia, Cardio-respiratory Arrest, Foetal Distress Syndrome, Hypotension
Patient was taking Inomax (View Usage). After Inomax was administered, patient had the following side effects: bradycardia, cardio-respiratory arrest, foetal distress syndrome, hypotension on Jan 03, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 7.94 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Inomax dosage: 20 Ppm; Cont; Inh.

5529997-3 | Acute Chest Syndrome, Lung Consolidation
Adverse event was reported on Nov 16, 2007 by a Female patient taking Inomax (View Usage) (Dosage: 80 Ppm; Cont; Inh, 40 Ppm; Cont; Inh, 6 Ml; Cont; Inh) was diagnosed with sickle cell anaemia and. Location: UNITED STATES , 17 years of age, weighting 170.2 lb, Patient experienced the following unwanted or unexpected effects: acute chest syndrome, lung consolidation. During the same period patient was treated with HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), NALOXONE (View Naloxone Review and Naloxone Label ), MORPHINE (View Morphine Review and Morphine Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ).

5510856-7 | Blood Count Abnormal, Post Procedural Haemorrhage
on Oct 31, 2007 Male patient from UNITED STATES , 65 years of age, weighting 221.8 lb, was diagnosed with ventricular assist device insertion and was treated with Inomax (View Usage). Patient had the following side effects: blood count abnormal, post procedural haemorrhage. Inomax dosage: 40 Ppm; Cont; Inh. During the same period patient was treated with DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ), VASOPRESSIN INJECTION (View Vasopressin Injection Review and Vasopressin Injection Label ), INSULIN (View Insulin Review and Insulin Label ), CALCIUM CHLORIDE ^SIOTIKA^ (View Calcium Chloride ^siotika^ Review and Calcium Chloride ^siotika^ Label ).

5442018-6 | Acute Chest Syndrome, Haemoglobin Decreased, Lung Disorder, Migraine, Ophthalmological Examination Abnormal, Pulmonary Congestion, Pyrexia
on Aug 23, 2007 Female patient from UNITED STATES , 28 years of age, weighting 207.0 lb, was diagnosed with sickle cell anaemia and was treated with Inomax (View Usage). After Inomax was administered, patient had the following side effects: acute chest syndrome, haemoglobin decreased, lung disorder, migraine (What is migraine?), ophthalmological examination abnormal, pulmonary congestion, pyrexia. Inomax dosage: 80 Ppm;cont;inh; 40 Ppm;cont;inh; 6ml;cont;inh. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), LOVENOX (View Lovenox Review and Lovenox Label ), PHENERGAN ^AVENTIS PHARMA^ (View Phenergan ^aventis Pharma^ Review and Phenergan ^aventis Pharma^ Label ), BENADRYL ^ACHE^ (View Benadryl ^ache^ Review and Benadryl ^ache^ Label ). Patient was hospitalized.

5339676-3 | Acute Chest Syndrome
Patient was taking Inomax (View Usage). Patient experienced the following unwanted or unexpected effects: acute chest syndrome on Feb 13, 2007 from UNITED STATES Additional patient health information: Male patient , 13 years of age, weighting 84.44 lb, was diagnosed with sickle cell anaemia and. Inomax dosage: See Image. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ), HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ), COLACE (View Colace Review and Colace Label ), ATARAX (View Atarax Review and Atarax Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

5290195-2 | Acute Chest Syndrome, Mycoplasma Infection, Pain In Extremity, Pneumonia
Adverse event was reported on Mar 27, 2007 by a Male patient taking Inomax (View Usage) (Dosage: See Image) was diagnosed with sickle cell anaemia and. Location: UNITED STATES , 17 years of age, weighting 177.3 lb, Patient had the following side effects: acute chest syndrome, mycoplasma infection, pain in extremity, pneumonia (What is pneumonia?). During the same period patient was treated with HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

5085451-7 | Hypoxia, Necrotising Colitis
on Aug 07, 2006 Male patient from FRANCE , child .1 years of age, was diagnosed with lung disorder and was treated with Inomax (View Usage). After Inomax was administered, patient had the following side effects: hypoxia, necrotising colitis. Inomax dosage: 5 Ppm; Inh_gas; Inh,; Cont.

5052891-1 | Blood Pressure Decreased, Device Leakage, Heart Rate Decreased, Oxygen Saturation Decreased, Pneumothorax
on Jul 07, 2006 Female patient from UNITED STATES , 15 years of age, weighting 108.5 lb, was diagnosed with hypoxia and was treated with Inomax (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, device leakage, heart rate decreased, oxygen saturation decreased, pneumothorax. Inomax dosage: 3.3 Ppm;cont;inh.

5051734-X | Blood Pressure Decreased, Heart Rate Decreased, Medical Device Complication, Oxygen Saturation Decreased
Patient was taking Inomax (View Usage). Patient had the following side effects: blood pressure decreased, heart rate decreased, medical device complication, oxygen saturation decreased on Jun 26, 2006 from UNITED STATES Additional patient health information: Female patient , 14 years of age, . Inomax dosage: Cont;inh.

5049705-2 | Convulsion, Feeling Cold, Fluid Overload, Haemorrhage Intracranial, Hypotension, Loss Of Consciousness, Occult Blood Positive, Oxygen Saturation Decreased, Pallor
Adverse event was reported on Apr 27, 2006 by a Female patient taking Inomax (View Usage) (Dosage: 40 Ppm; Cont; Inh) was diagnosed with ventricular assist device insertion and. Location: UNITED STATES , 61 years of age, weighting 139.3 lb, After Inomax was administered, patient had the following side effects: convulsion, feeling cold, fluid overload, haemorrhage intracranial, hypotension, loss of consciousness, occult blood positive, oxygen saturation decreased, pallor. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), DIPYRIDAMOLE (View Dipyridamole Review and Dipyridamole Label ), NIZATIDINE (View Nizatidine Review and Nizatidine Label ), ZOSYN (View Zosyn Review and Zosyn Label ), ZOCOR (View Zocor Review and Zocor Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5019557-5 | Cardiac Ventricular Disorder, Confusional State, Depressed Level Of Consciousness, Hemiplegia, Pleural Effusion, Thalamic Infarction, Ventricular Extrasystoles, Ventricular Tachycardia
on May 25, 2006 Male patient from UNITED STATES , 54 years of age, weighting 143.3 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Inomax (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac ventricular disorder, confusional state, depressed level of consciousness, hemiplegia, pleural effusion, thalamic infarction, ventricular extrasystoles, ventricular tachycardia. Inomax dosage: Cont. During the same period patient was treated with CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CALCIUM CHLORIDE (View Calcium Chloride Review and Calcium Chloride Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), MILRINONE (View Milrinone Review and Milrinone Label ).

4931237-0 | Multi-organ Failure, Right Ventricular Failure
on Feb 06, 2006 Male patient from GERMANY , 69 years of age, was diagnosed with medical device implantation and was treated with Inomax (View Usage). Patient had the following side effects: multi-organ failure, right ventricular failure. Inomax dosage: 40 Ppm;cont. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), AMIODARONE (AMIODARONE) (View Amiodarone (amiodarone) Review and Amiodarone (amiodarone) Label ), KETAMINE (KETAMINE) (View Ketamine (ketamine) Review and Ketamine (ketamine) Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), NORADRENALINE (NOREPINEPHRINE) (View Noradrenaline (norepinephrine) Review and Noradrenaline (norepinephrine) Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

4918296-6 | Coagulopathy, Haematoma, Haemodialysis, Hepatic Failure, Mediastinal Haemorrhage, Multi-organ Failure, Post Procedural Complication, Renal Failure, Respiratory Failure
Patient was taking Inomax (View Usage). After Inomax was administered, patient had the following side effects: coagulopathy, haematoma, haemodialysis, hepatic failure, mediastinal haemorrhage, multi-organ failure, post procedural complication, renal failure, respiratory failure on Feb 01, 2006 from UNITED STATES Additional patient health information: Female patient , 63 years of age, weighting 121.5 lb, was diagnosed with medical device implantation and. Inomax dosage: 20 Ppm; Cont; Inh. During the same period patient was treated with AMIODARONE (View Amiodarone Review and Amiodarone Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), SODIUM NITROPRUSSIDE (View Sodium Nitroprusside Review and Sodium Nitroprusside Label ), PROPOFOL (View Propofol Review and Propofol Label ), INSULIN (View Insulin Review and Insulin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MILRINONE (View Milrinone Review and Milrinone Label ).

4907398-6 | Cardiac Procedure Complication, Multi-organ Failure, Right Ventricular Failure
Adverse event was reported on Feb 06, 2006 by a Male patient taking Inomax (View Usage) (Dosage: 40 Ppm Cont) was diagnosed with medical device implantation and. Location: GERMANY , 69 years of age, Patient experienced the following unwanted or unexpected effects: cardiac procedure complication, multi-organ failure, right ventricular failure. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), KETAMINE (KETAMINE) (View Ketamine (ketamine) Review and Ketamine (ketamine) Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), NORADRENALINE (View Noradrenaline Review and Noradrenaline Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

4865409-0 | Bradycardia, Cardiac Arrest, Dilatation Ventricular, Haemoglobin Decreased, Hypotension, Hypoxia, Low Cardiac Output Syndrome, Mitral Valve Stenosis, Platelet Count Increased
on Dec 06, 2005 Male patient from SPAIN , child 2 years of age, was diagnosed with vasodilation procedure and was treated with Inomax (View Usage). Patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?), dilatation ventricular, haemoglobin decreased, hypotension, hypoxia, low cardiac output syndrome, mitral valve stenosis, platelet count increased. Inomax dosage: 80 Ppm, Cont. During the same period patient was treated with ULTANE (SEVOFLURANE) (View Ultane (sevoflurane) Review and Ultane (sevoflurane) Label ), ESMERON (ROCURONIUM BROMIDE) (View Esmeron (rocuronium Bromide) Review and Esmeron (rocuronium Bromide) Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), DOBUTAMINE (View Dobutamine Review and Dobutamine Label ), MILRINONE (View Milrinone Review and Milrinone Label ), SILDENAFIL (View Sildenafil Review and Sildenafil Label ), ....................... (View ....................... Review and ....................... Label ), MIDAZOLAM (View Midazolam Review and Midazolam Label ).

4851920-5 | Accident, Blood Calcium Decreased, Blood Gases Abnormal, Blood Glucose Increased, Blood Lactic Acid Increased, Blood Magnesium Increased, Blood Ph Decreased, Blood Sodium Decreased, Blood Urea Increased
on Jun 06, 2005 Male patient from SPAIN , child 4 years of age, was diagnosed with vasodilation procedure and was treated with Inomax (View Usage). After Inomax was administered, patient had the following side effects: accident, blood calcium decreased, blood gases abnormal, blood glucose increased, blood lactic acid increased, blood magnesium increased, blood ph decreased, blood sodium decreased, blood urea increased. Inomax dosage: 80 Ppm; Cont Inh. During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ESMERON (ROCURONIUM BROMIDE) (View Esmeron (rocuronium Bromide) Review and Esmeron (rocuronium Bromide) Label ), ATROPINE (View Atropine Review and Atropine Label ), DOBUTAMINE (DOBUTAMINE) (View Dobutamine (dobutamine) Review and Dobutamine (dobutamine) Label ), MILRINONE (MILRINONE) (View Milrinone (milrinone) Review and Milrinone (milrinone) Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ).

4831718-4 | Cardiac Disorder
Patient was taking Inomax (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac disorder on Nov 09, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 8.18 lb, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Inomax dosage: 20 Ppm; Cont; Inh.

4688327-X | Bradycardia, Hypotension, Hypoxia, Procedural Complication, Pulmonary Hypertension, Right Ventricular Failure, Ventricular Fibrillation
Adverse event was reported on Jun 06, 2005 by a Male patient taking Inomax (View Usage) (Dosage: 80 Ppm;cont) was diagnosed with vasodilation procedure and. Location: , child 4 years of age, Patient had the following side effects: bradycardia, hypotension, hypoxia, procedural complication, pulmonary hypertension (What is pulmonary hypertension?), right ventricular failure, ventricular fibrillation. During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ).

4587328-X | Electrocardiogram St Segment Elevation, Hypotension
on Feb 11, 2005 Female patient from , child 9 years of age, weighting 41.89 lb, was diagnosed with vasodilation procedure and was treated with Inomax (View Usage). After Inomax was administered, patient had the following side effects: electrocardiogram st segment elevation, hypotension. Inomax dosage: 80 Ppm; Cont; Inh. During the same period patient was treated with ESMERON (View Esmeron Review and Esmeron Label ), FENTANEST (View Fentanest Review and Fentanest Label ), MIDAZOLAM (View Midazolam Review and Midazolam Label ), SEVORANE (View Sevorane Review and Sevorane Label ).